Mo1309 CLINICAL VALUE OF ENDOSCOPIC ULTRASONOGRAPHY IN THE DIAGNOSIS AND THE TREATMENT OF UNDETERMINED COMMON BILE DUCT DILATATION
Han Ding,Ping-Hong Zhou,Mei-Dong Xu,Tao Chen,Wei-Feng Chen,Quan-Lin Li,Jian-Wei Hu,Ming-Yan Cai,Jingjing Lian,Yuan Huang,Yi-Qun Zhang
DOI: https://doi.org/10.1016/j.gie.2018.04.1959
IF: 10.396
2018-01-01
Gastrointestinal Endoscopy
Abstract:Unexplained common bile duct(CBD) dilatation may be caused by many etiologies,such as periampullary tumors，pancreatic neoplasms，choledocholithiasis and inflammatory stenosis.The etiologies are different and the corresponding treatments are completely different.The aim of this study was to evaluate the yield of EUS in patients with unexplained CBD dilatation and combine tumor markers,liver function,clinical symptoms,prior cholecystectomy and dilatation of pancreatic duct(PD) to analyze the influence of EUS diagnostic accuracy. From January 2016 to July 2017 in Zhongshan Hospital Affiliated to Fudan University Endoscopy Center,115 patients who were referred for evaluation of CBD dilatation but unable to identify the cause by imaging underwent EUS for the diagnosis of etiology.The next therapy would be developed on the basis of the diagnosis of EUS combine with tumor markers.Liver function, clinical symptoms, prior cholecystectomy and dilatation of PD were also retrospectively analyzed.Final diagnoses were determined by surgical pathology or follow-up for at least 3 months. A total of 115 patients were included，sensitivity,specificity and accuracy of EUS for patients with choledocholithiasis were 100.0%（10/10）,100.0%（105/105）,100.0%（115/115）,respectively .Sensitivity,specificity and accuracy of EUS for patients with periampullary tumor were 86.5%（32/37）,89.7%（70/78）,88.7%（102/115）,respectively.Sensitivity,specificity and accuracy of EUS for patients with inflammatory stenosis were 88.2%（60/68）,89.4%（42/47）,88.7%（102/115）,respectively.Accuracy of EUS for patients with undetermined etiology of CBD dilatation was 88.7%（102/115）,which is higher than the accuracy of US (64.1%),CT (66.2%),MRI (67.0%),PET-CT (66.0%) for CBD dilatation.Sensitivity,specificity,positive predictive value,negative predictive value and accuracy of EUS combined with tumor markers for patients with malignant dilatation of CBD were 91.9% (34/37) ,97.4% (76/78) ,94.4% (34/36) ,96.2% (76/79) and 95.7% (110/115), respectively.Among Liver function,clinical symptoms,prior cholecystectomy and PD dilatation,combination of PD dilation (p=0.026) and weight loss (p=0.035) has an impact on the diagnostic rate of EUS.The receiver operating characteristics curve (ROC) plotted to predict malignancy disclosed that the area under the curve (AUC) was 0.881 for EUS alone and 0.936 for EUS combined with PD dilation and weight loss,respectively. EUS is an effect method for the diagnosis of undetermined etiology of CBD dilatation and is of guiding significance in the treatment.EUS combined with tumor markers may be a reasonable choice for improving the identification of benign and malignant CBD dilatation.More attention should be paid in patients with PD dilation or weight loss to prevent misdiagnosis of malignant CBD.Tabled 1Table 1 Patient demographics and EUS findingsPatient demographicsValueAge (years)61.2 ± 12.1 (n = 115)Gender (M/F)50/65 (n = 115)Prior cholecystectomy27.0% (31/115)Clinical symptomsAbdominal pain60.9% (70/115)Jaundice31.3% (36/115)Fever11.3% (13/115)Nausea and emesis5.2% (6/115)Weight loss3.5% (4/115)No symptom20.0% (23/115)Tumor markersElevated CA19-931.3% (36/115)Elevated CEA12.2% (14/115)Liver functionElevated TBIL33.0% (38/115)Elevated ALT41.7% (48/115)Elevated ALP37.4% (43/115)EUS fingdings and diagnosisMean CBD (mm)12.6 ± 4.0 (n = 115)Mean dilated PD (mm)5.7 ± 3.3 (n = 29)Choledocholithiasis8.7% (10/115)Inflammatory stenosis56.5% (65/115)Periampullary tumor34.8% (50/115) Open table in a new tab